RICCI, BIANCAMARIA
 Distribuzione geografica
Continente #
NA - Nord America 352
EU - Europa 156
AS - Asia 19
AF - Africa 3
Totale 530
Nazione #
US - Stati Uniti d'America 351
IT - Italia 56
DE - Germania 31
AT - Austria 29
IN - India 10
FI - Finlandia 8
NL - Olanda 7
CN - Cina 6
FR - Francia 6
SE - Svezia 6
RU - Federazione Russa 5
BG - Bulgaria 4
SG - Singapore 3
TG - Togo 3
UA - Ucraina 3
CA - Canada 1
GB - Regno Unito 1
Totale 530
Città #
Fairfield 75
Rome 38
Seattle 34
Woodbridge 30
Ashburn 29
Vienna 26
Wilmington 23
Ann Arbor 22
Chandler 21
Houston 19
Cambridge 14
Dearborn 10
San Paolo di Civitate 8
Fasano 7
Paris 6
Plano 6
Princeton 6
Lawrence 5
Sofia 4
Lomé 3
Norwalk 3
Phoenix 3
San Diego 3
Boston 2
Millbury 2
New York 2
Beijing 1
Bremen 1
Dulles 1
Fremont 1
Fuzhou 1
Grafing 1
Hebei 1
Hefei 1
Helsinki 1
Jacksonville 1
La Jolla 1
Ottawa 1
Pavia 1
Pune 1
Washington 1
Wenzhou 1
Yellow Springs 1
Totale 418
Nome #
New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer 128
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation 125
Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells 94
The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro 74
Reactive Oxygen Species- and DNA Damage Response-Dependent NK Cell Activating Ligand Upregulation Occurs at Transcriptional Levels and Requires the Transcriptional Factor E2F1. 69
Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma 60
Totale 550
Categoria #
all - tutte 1.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.247


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201966 0 0 0 0 0 0 0 0 0 13 30 23
2019/2020126 14 5 1 7 14 19 23 13 14 7 3 6
2020/202179 1 6 1 1 5 1 6 2 9 33 7 7
2021/202267 0 4 8 2 6 0 2 6 1 7 16 15
2022/202384 14 30 5 10 8 7 0 1 7 1 0 1
2023/202433 0 7 1 2 1 13 1 6 0 2 0 0
Totale 550